Other

Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax Parent

West Pharmaceutical Services Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax Parent increased by 120.0% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 88.9%, from $900.00K to $100.00K.

Analysis

StatementIncome Statement
SectionOther
First reportedQ2 2024
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_other_comprehensive_income_loss_derivative_exclude_a25af4

Historical Data

6 periods
 Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$300.00K$1.10M$900.00K$800.00K-$500.00K$100.00K
QoQ Change—+266.7%-18.2%-11.1%-162.5%+120.0%
YoY Change———+166.7%-145.5%-88.9%
Range-$500.00K – $1.10M
CAGR-58.5%
Avg YoY Growth-22.6%
Median YoY Growth-88.9%

Frequently Asked Questions

What is West Pharmaceutical Services's other comprehensive income loss derivative excluded component increase decrease after adjustments tax parent?
West Pharmaceutical Services (WST) reported other comprehensive income loss derivative excluded component increase decrease after adjustments tax parent of $100.00K in Q1 2026.
How has West Pharmaceutical Services's other comprehensive income loss derivative excluded component increase decrease after adjustments tax parent changed year-over-year?
West Pharmaceutical Services's other comprehensive income loss derivative excluded component increase decrease after adjustments tax parent decreased by 88.9% year-over-year, from $900.00K to $100.00K.